Center for Scientific Review Amended Notice of Meeting, 58025 [2011-24011]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 181 / Monday, September 19, 2011 / Notices
Target Validation for Drug Resistant
Pathogens.
Date: October 13, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call.)
Contact Person: Yong Gao, PhD, Scientific
Review Officer, Scientific Review Program,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
Room 3127, Bethesda, MD 20892, 301–443–
8115, gaol2@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Chemical Approaches to
Target Validation for Drug Resistant
Pathogens.
Date: October 19, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call.)
Contact Person: Yong Gao, PhD, Scientific
Review Officer, Scientific Review Program,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
Room 3127, Bethesda, MD 20892, 301–443–
8115, gaol2@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Chemical Approaches to
Target Validation for Drug Resistant
Pathogens.
Date: October 21, 2011.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference
Call.)
Contact Person: Yong Gao, PhD, Scientific
Review Officer, Scientific Review Program,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
Room 3127, Bethesda, MD 20892, 301–443–
8115, gaol2@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24016 Filed 9–16–11; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Tumor Cell Biology
Study Section, October 10, 2011, 8 a.m.
to October 11, 2011, 5 p.m., Embassy
VerDate Mar<15>2010
15:46 Sep 16, 2011
Jkt 223001
Suites at the Chevy Chase Pavilion,
4300 Military Road, NW., Washington,
DC 20015 which was published in the
Federal Register on September 7, 2011,
76 FR 55402–55403.
The meeting will be held October 10,
2011 from 8 a.m. to 5 p.m. The meeting
location remains the same. The meeting
is closed to the public.
Dated: September 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24011 Filed 9–16–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung and Blood
Institute Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Gene Therapy Resource Program LentiVirus
Vector Production.
Date: October 7, 2011.
Time: 8:30 a.m. to 10 a.m.
Agenda: To review and evaluate contract
proposals.
Plae: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda MD 20814.
Contact Person: Tony L Creazzo, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Gene Therapy Resource Program
Pharmacology/Toxicology Core.
Date: October 7, 2011.
Time: 10 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD,
Scientific Review Officer, Office of Scientific
PO 00000
Frm 00079
Fmt 4703
Sfmt 9990
58025
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Gene Therapy Resource Program PreClinical
Vector Production Core.
Date: October 7, 2011.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Gene Therapy Resource Program AdenoAssociated Virus Vector Production Core.
Date: October 7, 2011.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Gene Therapy Resource Program Clinical
Coordinating Center.
Date: October 7, 2011.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Tony L Creazzo, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7180, Bethesda, MD 20892–7924, 301–435–
0725, creazzotl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–24005 Filed 9–16–11; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\19SEN1.SGM
19SEN1
]]>Agencies
[Federal Register Volume 76, Number 181 (Monday, September 19, 2011)]
[Notices]
[Page 58025]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-24011]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Tumor Cell
Biology Study Section, October 10, 2011, 8 a.m. to October 11, 2011, 5
p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road,
NW., Washington, DC 20015 which was published in the Federal Register
on September 7, 2011, 76 FR 55402-55403.
The meeting will be held October 10, 2011 from 8 a.m. to 5 p.m. The
meeting location remains the same. The meeting is closed to the public.
Dated: September 13, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-24011 Filed 9-16-11; 8:45 am]
BILLING CODE 4140-01-P
